Narcolepsy Market Research Report - Forecast to 2027

Narcolepsy Market Research Report, By Type (Type 1, Type 2 Narcolepsy) Diagnosis (Poysomnogram, Multiple Sleep Latency Test) Treatment (Stimulants, Antidepressants, Sodium Oxybate) End Users (Hospitals, Retail Pharmacies) – Global Forecast Till 2027

ID: MRFR/Pharma/4246-HCR | February 2021 | Region: Global | 90 pages         

Narcolepsy Market

Narcolepsy Market is expected to register a CAGR of 9.7 % with USD 6,776.80 Million by 2030

Segmentation

By Type Type 1 Type 2 Narcolepsy
By Diagnosis Poysomnogram Multiple Sleep Latency Test
By Treatment Stimulants Antidepressants Sodium Oxybate
By End-User Hospitals Retail Pharmacies

Key Players

  • Jazz Pharmaceuticals plc (Republic of Ireland)
  • BIOPROJET (Paris)
  • Ligand Pharmaceuticals Inc. (U.S.)
  • Shire (Republic of Ireland)
  • Arena Pharmaceuticals Inc. (U.S.)
  • Novartis AG (Switzerland)
  • Shionogi Inc. (U.S.)
  • Graymark Healthcare Inc. (U.S.)
  • Mylan N.V. (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)

Drivers

  • Growing awareness about narcolepsy
Speak to Analyst Request a Free Sample

Narcolepsy Market Overview:


The narcolepsy market is showing good signs of growth, especially during the ongoing forecast period. During the ongoing period that ends in 2028, the narcolepsy market is likely to grow and expand its operations at a global CAGR of 8.2%.


Narcolepsy can be understood as a medical condition that is characterized by overwhelming daytime drowsiness and experiencing sudden attacks of sleep. Sometimes, these chronic sleep disorders can lead to a sudden loss of muscle tone that is known as cataplexy. This leads to weakness and loss of muscle control, as well. Sleep paralysis and other issues like hallucinations, daytime sleepiness, fragmented sleep & insomnia, besides others are some of the most common symptoms of narcolepsy disease.


COVID 19 Analysis


The narcolepsy market has been one of the affected markets since the coronavirus infection has turned into a pandemic and is facing adversities ever since. The changing way of life and inclinations of individuals is a consequence of the pandemic that sped up a significant change in the useful examples of the market. The primary explanation for this is that the pandemic has introduced significant difficulties for industry and market verticles which are confronting issues to work. The inaccessibility of unrefined substance for the creation and assembling close by the strategic help nonattendance is pushing for a mass disturbance of the store network instrument. The examples of interest and assembling are distinctive in both the provincial and worldwide areas are vigorously affecting the capacity of the interest to work and the practical limitations that have been forced are likewise adding to the affliction.


Notwithstanding, to accomplish the past examples and advantage both the makers and interest groups, the public authority is putting resources into innovative work strategies to assist the narcolepsy market with growing a worldwide scale. Likewise, the key market players are and route to curating inventive and imaginative items and dispatching them for an enormous scope. This is being done to assist them with perceiving the items and requests according to the accessibility likewise.


Market Dynamics


Drivers


The narcolepsy market size is witnessing the emergence of various market factors that will drive the global market towards growth amid the ongoing forecast period that will be ending in 2028. There has been an increase in the prevalence of narcolepsy and the growing degree of the obese population are the major drivers of narcolepsy market growth during the forecast period of 2021-2028. According to the stats that have been circulated by the Sleep Science journal in 2017, it was estimated that approximately 1 in every 2,000 people across the global scale lives with narcolepsy. Moreover, from the period of 2014-2015, the Australian Institute of Health and Welfare stated that approximately two-thirds, i.e., 63% of the Australian population aged 18 years and more were estimated to be overweight or obese and had higher chances of contracting the disease.


Restraints


However, the narcolepsy market size is witnessing the emergence of factors that might restrain the market from growing as per the predictions for the market. There has been a reduced availability of information and awareness that will hamper the market from growing in the international market premises.


Technology Analysis


There has been a rising number of people who are suffering from a host of narcoleptic disorders, which are inclusive of hallucinations, sleep paralysis, disrupted nocturnal sleep, and obesity. These issues are prevalent that have caught the attention of governments around the world. This attention is forcing them to take the necessary steps to address this condition. For instance, there has been the establishment of awareness campaigns that are conducted by various networks, including the National Center on Sleep Disorders Research. These help to address the needs of individuals with serious or mild narcoleptic conditions.


Study Objectives



  • The narcolepsy market aims to have significant market experiences and outline close by the perspectives as advanced by the business chiefs and specialists to foresee the CAGR pace of development of the market and the market valuation during 2021-2028

  • The market aims to concentrate on the extent of the market during the estimated time frame by seeing the market patterns and fragment execution in major geological locales of the globe. The market report aims to have a deep understanding based on which the global narcolepsy market has been segmented. The report further helps to understand the potential of the market segments to meet the rising needs of the people and help the market players understand the demand patterns so that they can produce and manufacture accordingly.

  • The market report aims to have an outline of the serious degree winning in the market among the key market players during the period and break down the new improvements attempted by the local players for worldwide rivalry and competition amid the market operations that are at different stages of completion during the ongoing forecast period that will be ending in 2028.


Segment Overview


The narcolepsy market revenue is rising because of the excellent performance of the following market segments which are stated below:


Based on the market type


The narcolepsy market is segmented based on the type and includes type 1 narcolepsy, type 2 narcolepsy, and others.


Based on the market diagnosis


The narcolepsy market has been categorized into polysomnograms, multiple sleep latency tests, amongst others.


Based on the market treatment


The market is segmented based on the market treatment and includes stimulants, antidepressants, sodium oxybate, and others. The stimulants segment is further, sub-segmented into modafinil, armodafinil, and others. The antidepressants segment is further sub-segmented into tricyclics, selective serotonin and noradrenergic reuptake inhibitors, and others. The tricyclics segment has been additionally segmented into imipramine, desipramine, clomipramine, and others. The selective serotonin and noradrenergic reuptake inhibitors segment are sub-segmented and are inclusive of venlafaxine, fluoxetine, and others.


Based on the end-users


The market has been segmented into the end-user industries and includes hospitals, clinics, retail pharmacies, and others.


Regional Analysis


The North American region is likely to dominate the narcolepsy market. The main reason behind this is the well-developed healthcare sector along with high healthcare expenditure and a huge patient pool and population. According to the stats that have been circulated by the National Institute of Neurological Disorders and Stroke in 2018, it is estimated that 135,000 to 200,000 people in the United States, as a part of the North American market are living with narcolepsy. Moreover, there is a rising presence of developed economies like the U.S. and Canadian market alongside the global players such as Mylan N.V., Ligand Pharmaceuticals, Inc., amongst others. These are functioning within the regional boundaries of the American region that fuels the narcolepsy market growth.


Competitive Landscape


The narcolepsy market share is rising because of the performance of the following market players:



  • Jazz Pharmaceuticals plc (Republic of Ireland)

  • BIOPROJET (Paris)

  • Ligand Pharmaceuticals, Inc. (U.S.)

  • Shire (Republic of Ireland)

  • Arena Pharmaceuticals, Inc. (U.S.)

  • Novartis AG (Switzerland)

  • Shionogi Inc. (U.S.)

  • Graymark Healthcare, Inc. (U.S.)

  • Mylan N.V.  (U.S.)

  • Teva Pharmaceutical Industries Ltd. (Israel)


Recent Developments


The European market is likely to witness the second-largest growth for narcolepsy and the trends are followed by the Asia Pacific. The aim behind this is the availability of funds for research, the huge patient population, and the growing number of obese, and the presence of developed economies like France, Italy, and Germany within the domestic region.


The Asian Pacific region is estimated to be the fastest-growing region for the narcolepsy market. There has been a reliable presence of developing economies like India and China within the region. These countries are witnessing the development of the healthcare sector that facilitates regional market growth. Moreover, there has been a rise in favorable government policies that will boost the narcolepsy market growth.


Saudi Arabia, Qatar, and Kuwait are the regions that are witnessing a rise in trends that will help in propelling the market growth during the period that will be ending in 2028.


Intended Audience


Global narcolepsy treatment manufacturers, wholesalers, dealers, and suppliers


Research and development (R&D) firms, groups, and companies



  • Vaccine importers and exporters

  • Government

  • Public sector

  • Importers and exporters

  • Hospitals, healthcare centers, and clinics

  • Academic institutions and universities


Report Overview


The narcolepsy market report is a combination of the diverse market factors that will help the market and lead the way towards the growth scale and the possible challenges that have been predicted by the experts for the forecast period of 2021-2028. The market report helps to understand the recent developments that have been undertaken by the industry and the ones like investments or mergers that will lead to expansion in the ongoing forecast period that will be ending in 2028.



Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

Narcolepsy is a medical condition wherein the patient suffers from chronic drowsiness during the day and sudden attacks of sleep.

Narcolepsy Market is expected to exhibit a strong 8.2% CAGR over the forecast period till 2023.

Growing awareness about narcolepsy is the major driver for the Narcolepsy Market.

The Americas dominate the global Narcolepsy Market, followed by Europe.

Leading players in the Narcolepsy Market include Arena Pharmaceuticals, BIOPROJET, and Jazz Pharmaceuticals, among others.